Deep-pocketed investors have adopted a bearish approach towards Roblox RBLX, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

Hunty Zombie is a brand new experience on the Roblox platform where you use various weapons along with traits, passive bonuses from pets, and such things to hunt down zombies. The gameplay loop is ...

It’s the heart of earnings season, so imagine how well you could trade if you had a company’s financials before everyone else. The answer, according to a new study of a famous hacking spree, might be ...

Pop Mart's net profit soared 396.5% for the first six months of 2025. In June, Chinese state media urged stricter oversight of blind-box toys and trading cards. Shares in Chinese toymaker Pop Mart saw ...

China’s Pop Mart says it is rolling out a mini version of its popular Labubu plush toys this month, along with a new long-fur version of the toothy little monster. The Labubu, by artist and ...

Roblox is an extremely popular online gaming platform. Far from giving signs that it is shutting down, last year, the company announced a series of upgrades. In fact, on Aug. 22, the company's stock ...

Wedbush sees Roblox as a top growth play despite legal challenges, citing strong safety measures and viral game momentum. Analysts project 41–45% Q3 bookings growth and highlight expanding ad ...

A new series of Labubus is about to hit the market, and the company's big announcement introduces a mini version of the popular accessory. Pop Mart's new "THE MONSTERS Pin for Love Series" Labubu ...

Pop Mart will be restocking its latest Labubu, the smaller "Pin for Love" series that was released on Aug. 28, according to the Pop Mart website. The popular blind box will be available for purchase ...

Pop Mart will make pre-orders available once again for its "Big into Energy" Labubu on the same day it launches the new "Pin for Love Series" Labubu bag charms and a Labubu doll that is over a foot ...

In mid-July, the stock for the cancer drug developer MEI Pharma skyrocketed. It wasn’t because the small company, first listed on the Nasdaq in 2003, had discovered a blockbuster cancer cure. Rather, ...